Does Nadolol Interact with Insulin Human?
Nadolol and Insulin Human have a moderate drug interaction according to U.S. FDA drug labeling data. Nadolol may cause hypoglycemia or hyperglycemia; adjust dosage of insulin accordingly. The mechanism involves beta-blocker effects on glucose metabolism. Patients taking both medications should consult their healthcare provider before starting, stopping, or changing the dosage of either drug. This information is based on official FDA drug labeling sourced from OpenFDA and the NIH National Library of Medicine.
- Severity
- Moderate
- Nadolol Class
- beta-Adrenergic Blocker
- Insulin Human Class
- Insulin
- Management
- Monitor for effects
- Data Source
- U.S. FDA via OpenFDA
How This Interaction Works
The interaction between Nadolol and Insulin Human occurs because beta-blocker effects on glucose metabolism. Clinically, this means nadolol may cause hypoglycemia or hyperglycemia; adjust dosage of insulin accordingly. This is classified as a moderate interaction. While it may not require stopping either medication, your healthcare provider should be aware you are taking both so they can monitor for potential effects and adjust treatment if necessary.
What To Tell Your Doctor or Pharmacist
If you are taking Nadolol and your doctor is considering prescribing Insulin Human (or vice versa), make sure to:
- Inform your doctor and pharmacist of all current medications, including over-the-counter drugs and supplements
- Ask whether the benefits of combining these medications outweigh the risks for your specific situation
- Ask what symptoms to watch for that would indicate the interaction is causing problems
- Ask whether any dosage adjustments are needed
- Never stop or change either medication without first consulting your healthcare provider